Bradley Pharmaceuticals Inc - Amended Termination of Registration of a Class of Security under Section 12(g) (15-12G/A)
2008年2月22日 - 7:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND
NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR
SUSPENSION OF DUTY TO
FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE
SECURITIES EXCHANGE ACT OF 1934
Commission File Number
0-31680
Bradley
Pharmaceuticals, Inc.
(Exact name of registrant as
specified in its charter)
383 Route 46 West,
Fairfield, NJ 07004-2402
(973) 882-1505
(Address, including zip
code, and telephone number, including area code, of registrants principal executive
offices)
Common Stock, $0.01
par value
(Title of each class of securities covered by
this Form)
Please place an X in the box(es) to
designate the appropriate rule provision(s) relied upon to terminate or suspend the duty
to file reports:
|
Rule 12g-4(a)(1)(i)
|
|X|
|
|
Rule 12h-3(b)(1)(i)
|
|X|
|
|
|
Rule 12g-4(a)(1)(ii)
|
|_|
|
|
Rule 12h-3(b)(1)(ii)
|
|_|
|
|
|
Rule 12g-4(a)(2)(i)
|
|_|
|
|
Rule 12h-3(b)(2)(i)
|
|_|
|
|
|
Rule 12g-4(a)(2)(ii)
|
|_|
|
|
Rule 12h-3(b)(2)(ii)
|
|_|
|
|
|
|
|
|
Rule 15d-6
|
|_|
|
|
Approximate number of holders of
record as of the certification or notice date: Common Stock, $0.01 par value: 1
Pursuant
to the requirements of the Securities Exchange Act of 1934, Bradley Pharmaceuticals, Inc.
has caused this certification/notice to be signed on its behalf by the undersigned duly
authorized person.
|
BRADLEY PHARMACEUTICALS, INC.
|
|
|
|
February 21, 2008
|
By:
|
/s/ Paul McGarty
Name: Paul McGarty
Title: President and Chief
Executive Officer
|
Bradley (NYSE:BDY)
過去 株価チャート
から 6 2024 まで 7 2024
Bradley (NYSE:BDY)
過去 株価チャート
から 7 2023 まで 7 2024
Real-Time news about Bradley Pharmaceuticals (ニューヨーク証券取引所): 0 recent articles
その他のBradley Pharmaceuticals Incニュース記事